Stocktoria
Humacyte, Inc. HUMA
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-09-22
Humacyte, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 7,140,014 | $34.3M | 3.7% |
| AQR CAPITAL MANAGEMENT LLC | 2,597,134 | $2.0M | 1.35% |
| MILLENNIUM MANAGEMENT LLC | 1,971,549 | $1.5M | 1.02% |
| CITADEL ADVISORS LLC | 1,869,076 | $1.5M | 0.97% |
| Point72 Asset Management, L.P. | 53,728 | $41,929 | 0.03% |
| TWO SIGMA INVESTMENTS, LP | 29,548 | $23,059 | 0.02% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.